Epilepsy Surgery Market Poised for Steady Growth Driven by Advancements in Surgical Procedures and Rising Prevalence of Epilepsy.Pune, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Epilepsy Surgery Market Size & ...

NeuroPace, Inc., a medical device company focused on improving the lives of individuals with epilepsy, has announced that an abstract from its Post-approval Study of the RNS System will be ...

Responsive neurostimulation (RNS) is an innovative treatment option for individuals suffering from drug-resistant epilepsy, particularly when traditional medications fail to control seizures.

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

Orientation to the pediatric unit for new RNs was revised to include a lecture by a pediatric epileptologist explaining seizures, different types of epilepsy, the goals of seizure monitoring ...

uncertainties related to market acceptance and adoption of NeuroPace’s RNS System and impacts to NeuroPace’s revenue for 2025 and in the future; risks that NeuroPace’s operating expenses ...

NeuroPace provided initial financial guidance targets for 2025: Revenue of $92 million – $96 million, representing growth of 15.5% – 20.5% versus the midpoint of the expected 2024 revenue range of $79 ...

Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements as a result of various factors, including: actual operating ...